Short-course adjuvant trastuzumab in breast cancer: Experience from a tertiary cancer center in rural India

Short-course adjuvant trastuzumab in breast cancer: Experience from a tertiary cancer center in rural India

Introduction: Majority of the patients in low-to-middle income countries (LMICs) have no access to adjuvant trastuzumab due to financial constraints. Short-course (9 weeks) schedule of trastuzumab is a feasible alternative in this setting. The objective of this study was to assess the feasibility an...

Full description

Bibliographic Details
Main Authors: Avaronnan Manuprasad, Praveen Kumar Shenoy, Joneetha Jones, N V Vinin, Adarsh Dharmarajan, Geetha Muttath
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
breast cancer
india
short course
trastuzumab
lmic
her2
brca
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=1;spage=69;epage=73;aulast=Manuprasad

Internet

http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=1;spage=69;epage=73;aulast=Manuprasad

Similar Items